|
Re: Apabetalone......a Calculated Risk
|
3
|
Resverlogix Corp.
|
Apr 07, 2019 09:19PM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
5
|
Resverlogix Corp.
|
Mar 18, 2021 08:10AM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
5
|
Resverlogix Corp.
|
Jan 12, 2021 02:28PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
4
|
Resverlogix Corp.
|
Jan 12, 2021 03:25PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
8
|
Resverlogix Corp.
|
Jan 13, 2021 07:04AM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
10
|
Resverlogix Corp.
|
Jan 12, 2021 10:40AM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
8
|
Resverlogix Corp.
|
Jan 13, 2021 05:16PM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 09:26PM
|
|
Re: Apropos AGM
|
2
|
Resverlogix Corp.
|
Jun 09, 2022 11:32AM
|
|
Re: Are BP doing their DD already on Apabetalone,..
|
3
|
Resverlogix Corp.
|
Feb 14, 2019 12:41PM
|
|
Re: Are BP doing their DD already on Apabetalone,..
|
|
Resverlogix Corp.
|
Feb 14, 2019 01:30PM
|
|
Re: Are BP doing their DD already on Apabetalone,..
|
3
|
Resverlogix Corp.
|
Feb 14, 2019 02:50PM
|
|
Re: As we appear to have a flat tire down at the registry...you then read this from Fauci!
|
3
|
Resverlogix Corp.
|
May 09, 2021 11:55AM
|
|
Re: As we appear to have a flat tire down at the registry...you then read this from Fauci!
|
4
|
Resverlogix Corp.
|
May 07, 2021 08:45AM
|
|
Re: At 1.33 we're over both the 20 and 50 DMAs....
|
4
|
Resverlogix Corp.
|
Jun 08, 2016 06:26PM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
7
|
Resverlogix Corp.
|
May 06, 2016 07:24AM
|
|
Re: August 28th
|
3
|
Resverlogix Corp.
|
Aug 20, 2017 08:37PM
|
|
Re: Avoid The Bag - Blog post preview....
|
2
|
Resverlogix Corp.
|
Mar 30, 2017 07:48PM
|
|
Re: Award of deferred shares and restricted shares
|
5
|
Resverlogix Corp.
|
Dec 21, 2020 01:38PM
|
|
Re: Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach.
|
7
|
Zenith Epigenetics
|
Mar 31, 2020 02:23PM
|
